Randall Moreadith, Chief Scientific Officer at Serina Therapeutics, Inc. (SER), sold 1,245 shares at $3.31 ($4K) on 2025-12-09, disclosed to the SEC on 2025-12-11.
Open-market sale of $4k SER by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.31 | 600 | $2K | 47.9% |
| 2 | $3.35 | 645 | $2K | 52.1% |
| Total | $3.33 avg | 1,245 | $4K | 100% |
| Filing → |
| SER | SELL | 2026-02-03 | $20K | — | Filing → |
| SER | SELL | 2026-01-29 | $23K | — | Filing → |
| SER | SELL | 2026-01-23 | $7K | — | Filing → |